Your catalyst for

Strategic Partnership

Proventa International is a management consulting company, specialising in life sciences business development services, with a truly global reach.

Unique experiences

We’re committed to delivering long-term value across our extensive life science network. Through our carefully crafted meetings, collaborative experiences and services Proventa International can offer you the perfect opportunity to meet your business goals, whatever they may be.

Whether you’re seeking answers to the industry’s biggest challenges, investing in new innovations or hoping to identify your next key partnership – Proventa International can help you get there.

What we offer

Drug Discovery

Our events and services provide the ideal opportunity for pharmaceuticals, biotech and service providers to take the next step in the drug development process.

Strategy Meetings
Distinctive events

Strategy Meetings

Intimate format events where senior leadership discuss the biggest challenges facing the industry.

Making connections


Helping launch the next generation of life-changing medicines. Meet the investors hoping to make a difference.

Business development


Meet those hard to reach clients, no matter where they are. Personalised services in every corner of the globe.

About PharmaFeatures

PharmaFeatures provides thought-leading interviews, industry reports and innovative daily content on the newest trends and breaking news across life sciences. In addition to clients within the pharmaceutical space, PharmaFeatures tailors to readers in biotechnology, clinical research, bioinformatics and more.

Understanding the Future of Trial Design in Oncology: An Interview with Dr. Amit Agarwal, Arch Oncology 07th Dec 2021 07th Dec 2021
Clinical Operations

Understanding the Future of Trial Design in Oncology: An Interview with Dr. Amit Agarwal, Arch Oncology

An interview with Dr. Amit Agarwal of Arch Oncology regarding current developments in the area of clinical trials in oncology.

The Story So Far: SARS-CoV-2 Omicron 06th Dec 2021 06th Dec 2021

The Story So Far: SARS-CoV-2 Omicron

An update on the Omicron Variant of Concern of SARS-CoV-2 and the societal and industrial action needed to anticipate the evolution of COVID-19

Pharma Investment Roundup 02/12/2021 02nd Dec 2021 02nd Dec 2021
Daily News

Pharma Investment Roundup 02/12/2021

A summary of partnerships and acquisitions in the pharmaceutical and biotech industry in the week ending 02 Dec 2021.

join life science leaders

Interested? See for yourself

Take the first step and see where Proventa International can take you. Join one of our unique one-day strategy meetings.